Vanda Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ US9216591084

SecurityVNDA / Vanda Pharmaceuticals Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in VNDA / Vanda Pharmaceuticals Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Vanda Pharmaceuticals Inc. (US:VNDA) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 11,417 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (VNDA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VNDA / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -11,417 -100.00 0 -100.00
2025-08-18 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 11,417 11,417 55 0.0001
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -10,495 -100.00 0 -100.00
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 10,495 -1,622 -13.39 50 -10.71 0.0000
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 12,117 12,117 57 0.0001
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -11,101 -100.00 0 -100.00
2024-02-14 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 11,101 11,101 47 0.0000
2019-08-20 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -12,793 -100.00 0 -100.00
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 12,793 -1,884 -12.84 235 44.17 0.0007
2016-08-17 2016-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 14,677 14,677 163 0.0009
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 14,677 163
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM Call 11,400 -24.00 54 -22.86 n/a n/a n/a
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM Call 15,000 -81.53 70 -84.72 n/a n/a n/a
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM Call 81,200 459 n/a n/a n/a
2021-11-12 2021-09-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-06 2021-06-30 13F VANDA PHARMACEUTICALS COM Call 10,800 220 n/a n/a n/a
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-20 2019-06-30 13F VANDA PHARMACEUTICALS COM Call 15,900 -47.18 224 -59.57 n/a n/a n/a
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM Call 30,100 -7.67 554 -33.81 n/a n/a n/a
2019-02-13 2018-12-31 13F VANDA PHARMACEUTICALS COM Call 32,600 124.83 837 151.35 n/a n/a n/a
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM Call 14,500 -3.33 333 31.62 n/a n/a n/a
2018-08-13 2018-06-30 13F VANDA PHARMACEUTICALS COM Call 15,000 0.00 253 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM Call 15,000 -65.99 253 -64.71 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM Call 44,100 200.00 717 339.88 n/a n/a n/a
2016-08-17 2016-06-30 13F/A VANDA PHARMACEUTICALS COM Call 14,700 163 n/a n/a n/a
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM Call 147 163 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F VANDA PHARMACEUTICALS COM Put 10,000 -7.41 48 -6.00 n/a n/a n/a
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM Put 10,800 51 n/a n/a n/a
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM Put 11,000 62 n/a n/a n/a
2020-08-13 2020-06-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-11 2020-03-31 13F VANDA PHARMACEUTICALS COM Put 10,300 -8.85 100 -45.95 n/a n/a n/a
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS COM Put 11,300 9.71 185 85.00 n/a n/a n/a
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-20 2019-06-30 13F VANDA PHARMACEUTICALS COM Put 10,500 -42.62 148 -56.08 n/a n/a n/a
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM Put 18,300 51.24 337 8.71 n/a n/a n/a
2019-02-13 2018-12-31 13F VANDA PHARMACEUTICALS COM Put 12,100 -33.88 310 -8.01 n/a n/a n/a
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F VANDA PHARMACEUTICALS COM Put 10,900 0.00 184 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM Put 10,900 -42.02 184 -39.87 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM Put 18,800 -3.59 306 41.01 n/a n/a n/a
2016-08-17 2016-06-30 13F/A VANDA PHARMACEUTICALS COM Put 19,500 217 n/a n/a n/a
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM Put 195 217 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.